Basic Info
  • Factory Location: Zhejiang

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: T/T

    Anastrozole is indicated as adjunct therapy in the treatment of hormone receptor-positive early breast cancer in postmenopausal women, and as a first-line treatment for hormone receptor-positive (or hormone receptor-unknown) locally advanced or metastatic breast cancer in postmenopausal women. 

Send your message to this supplier
  • From:
  • To:
    Zhejiang Hisun Pharma. Co., Ltd.
  • Verification Code:
  • Message:

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now